CRISPR uni­corn Mam­moth backs off di­ag­nos­tics re­search, lay­ing off 35 on test­ing team to fo­cus on ther­a­peu­tics

Mam­moth Bio­sciences is tak­ing a big step away from its orig­i­nal am­bi­tion of up­end­ing the di­ag­nos­tics busi­ness with CRISPR, and has laid off the bulk …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.